Juno Therapeutics Competitors and Similar CompaniesClear all
Juno Therapeutics's competitors and similar companies include Immatics.
 Juno Therapeutics Juno Therapeutics is a clinical-stage company, which develops immunotherapies for the treatment of cancer. |  Immatics Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer. | |
Type | Type Subsidiary | Type Public |
Tags | ||
Locations | Locations Seattle, US HQ Göttingen, DE Göttingen, DE München, DE München, DE Bothell, US Brisbane, US | Locations Tübingen, DE HQ Frankfurt Am Main, DE München, DE Houston, US |
Employees | Employees 1091% decrease | Employees 29723% increase |
Financial | ||
Revenue (est.) | Revenue (est.) $111.9m (FY, 2017) | Revenue (est.) €48.3m (FY, 2025) |
Net income | Net income ($437.1m) (FY, 2017) | Net income (€196.4m) (FY, 2025) |
Funding | ||
Total funding raised | Total funding raised $ 310m | Total funding raised $ 267.3m |
For sources of this data, please see the company profile
View Company Profiles
Immatics
HQ
Tübingen, DE
Employees
297↑ 23% increase
Immatics is a biotechnology company that is primarily engaged in the research and development of T cell redirecting immunotherapies for the treatment of cancer.
View company